INTERNATIONAL PATENT: LANTERN PHARMA INC. FILES APPLICATION FOR "TREATING PEDIATRIC CANCERS WITH HYDROXYUREAMETHYL ACYLFULVENE"

GENEVA, March 31 -- LANTERN PHARMA INC. (1920 McKinney Ave, 7th FloorDallas, TX 75201) filed a patent application (PCT/US2025/047430) for "TREATING PEDIATRIC CANCERS WITH HYDROXYUREAMETHYL ACYLFULVENE" on Sep 22, 2025. With publication no. WO/2026/064751, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BHATIA, Kishor (1920 McKinney Ave., 7th FloorDallas, TX 75201), KULKARNI, Aditya (1920 McKinney Ave., 7th FloorDallas, TX 75201)

Abstract: Disclosed are methods, compositions, and kits for treating pediatric cancers using ...